Matthias Hebben

Matthias Hebben serves as Chief Technology Officer at Complement Therapeutics. Complement Therapeutics operates in the biotechnology sector with approximately 33.0 employees. Complement Therapeutics generates annual revenue of 1000000.0. To date, Complement Therapeutics has raised 84807330.0 in total funding, with the most recent round being Series A.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • Our database includes 201,464 c suite-level executives.

Outlook MailChimp SPF Microsoft Office 365 Salesforce Remote Basis

complement system complement medicine therapeutic development gene therapy protein therapy amd treatment age-related macular degeneration geographic atrophy systemic diseases clinical trials preclinical development fhr proteins complement dysregulation precision medicine systemic blood sample analysis mass spectrometry platform patient stratification disease monitoring complement-mediated diseases innovative therapies clinical needs immune system ocular diseases translational research therapeutic approaches novel therapeutics aav gene therapies drug discovery chronic renal disease neurological conditions multiple sclerosis alzheimer's disease pathogenesis research complement inhibition scientific expertise market needs biopharmaceutical solutions biotech startup environment platform technology cell therapy impact of genetic variants research collaborations clinical focus drug innovation complement precision medicine platform scalable manufacturing processes medical advisory board investor partnerships health care health wellness & fitness hospital & health care

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

CH

Chris Harano President and CEO at Advanced BioCatalytics

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Matthias Hebben, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Matthias Hebben's Position in the MessageCEO Database

• •Matthias Hebben is 1 of 1 verified executive contact we track at Complement Therapeutics.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •6 verified contacts work at biotechnology companies in the 33.0 employee range (same size as Complement Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Matthias Hebben directly?

Matthias Hebben's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Complement Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Matthias Hebben work for?

Matthias Hebben is Chief Technology Officer at Complement Therapeutics, a company in the biotechnology sector with 33.0 employees.

Can I pitch or sell to Matthias Hebben?

As Chief Technology Officer at Complement Therapeutics, Matthias Hebben is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Matthias Hebben directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Matthias Hebben in?

Matthias Hebben works in the biotechnology industry as Chief Technology Officer at Complement Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Matthias Hebben's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Matthias Hebben's profile is kept up-to-date with the latest available information.

Last updated: November 5, 2026